Advertisement

Topics

Ketamine could become the first new depression drug in more than 30 years

17:31 EDT 16 Apr 2018 | Topix

Johnson & Johnson is actively pursuing a nasal formulation of the drug. Researchers plan to present the results of an advanced clinical trial of the formula next month at the American Psychiatric Association meeting.

Original Article: Ketamine could become the first new depression drug in more than 30 years

NEXT ARTICLE

More From BioPortfolio on "Ketamine could become the first new depression drug in more than 30 years"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...